This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Ventria Biosciences Inc., Invitria, Inc., Ventria Bioscience. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fort Collins, CO (US) (2020)
- Junction City, KS (US) (2021 - 2022)
Company Filing History:

Years Active: 2020-2025
Title: Innovations of Steven Clyde Pettit
Introduction
Steven Clyde Pettit is an accomplished inventor based in Junction City, Kansas, with a notable portfolio of four patents. His work primarily focuses on advancements in cell culture media, which are essential for various biotechnological applications.
Latest Patents
Pettit's latest patents include innovative methods for enhancing transfection in cell culture media. One of his inventions relates to cell culture media supplemented with a plant-produced recombinant mammalian transferrin supplement. This invention aims to improve the growth characteristics of cultured cells for transfection. Another significant patent involves cell culture media compositions that comprise plant-produced heterologous recombinant human albumin. This invention also includes methods for making the cell culture media and using it to enhance the viability, productivity, and growth characteristics of cultured cells.
Career Highlights
Throughout his career, Pettit has made significant contributions to the field of biotechnology. He has worked with Ventria Biosciences Inc. and Ventria Bioscience, where he has applied his expertise in developing innovative solutions for cell culture applications.
Collaborations
Some of his notable coworkers include Mary Ann Michelle Fernandez Santos and Ning Huang, who have collaborated with him on various projects.
Conclusion
Steven Clyde Pettit's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant innovator in cell culture media development. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile